Theravance Biopharma Inc (TBPH)
CapEx to Revenue
0.00%
Quarterly · Period ending:
TBPH CapEx to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
TBPH Quarterly CapEx/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
TBPH capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0.0174% | |
| 0% | |
| 0.1298% | |
| 0% | |
| 1.0131% | |
| 0.0889% | |
| 0.2525% | |
| 0.6275% | |
| 3.8543% | |
| 0.1338% | |
| 6.1968% | |
| 9.0045% | |
| 1.8158% | |
| 0.4578% | |
| 1.0226% | |
| 1.8945% | |
| 2.9707% | |
| 7.8748% | |
| 1.208% | |
| 12.3939% | |
| 6.6418% | |
| 11.2286% | |
| 15.7783% | |
| 4.8031% | |
| 4.4171% | |
| 0.6196% | |
| 2.2027% | |
| 22.855% | |
| 9.5317% | |
| 14.6051% | |
| 4.6601% | |
| 33.3093% | |
| 5.6478% | |
| 19.3216% | |
| 21.0316% | |
| 19.0152% | |
| 7.0274% | |
| 2.1651% | |
| 11.6615% | |
| 3.7154% | |
| 15.5664% | |
| 6.3002% | |
| 9.9523% | |
| 3.2204% | |
| 53.3845% | |
| 7.2759% | |
| 8.7761% | |
| 171.4286% | |
| 609.1429% | |
| 987.5% | |
| 13,820% | |
| 3,363.6364% | |
| 5.8311% | |
| 0% |